Journal: Scientific Reports
Article Title: MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy
doi: 10.1038/srep27589
Figure Lengend Snippet: Male MC1R e/e mice and wild-type (WT) littermates aged 8 weeks were treated with saline or lipopolysaccharide (LPS, 200 μg) intraperitoneally. One hour before and 12 h after LPS or saline injection, mice received subcutaneous injection of NDP-MSH (0.6 μmol/kg wt ) or an equal amount of saline. Mice were followed for 24 h. ( a ) Urine was collected and processed for urine albumin ELISA assay adjusted for urine creatinine concentrations. # P < 0.05 vs control group (n = 6); * P < 0.05 vs LPS group (n = 6). ( b ) Kidney cortical tissues were procured at 24 h and processed for transmission electron microscopy. LPS injury caused marked ultrastructural signs of podocytopathy, characterized by microvillous transformation and a variable degree of foot process effacement (black arrowheads). This effect was attenuated by NDP-MSH treatment equally in MC1R e/e mice and WT littermates. Scale bar = 1 μm. ( c ) Morphometric analysis of the number of foot processes per micrometer of glomerular basement membrane (GBM) by electron microscopy. # P < 0.01 vs control group (n = 6); * P < 0.05 vs LPS group (n = 6).
Article Snippet: Urine albumin concentration was measured using a mouse albumin enzyme-linked immunosorbent assay (ELISA) quantitation kit (Bethyl Laboratories Inc., Montgomery, TX).
Techniques: Saline, Injection, Enzyme-linked Immunosorbent Assay, Control, Transmission Assay, Electron Microscopy, Transformation Assay, Membrane